Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2005, p. 10989-11004, Vol. 25, No. 24
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.24.10989-11004.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Howard Hughes Medical Institute, Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104
Received 22 June 2005/ Returned for modification 27 July 2005/ Accepted 19 September 2005
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The process of bringing the protein and RNA components together during U snRNP assembly in the cytoplasm is mediated by and dependent upon the survival of motor neurons (SMN) protein complex (3, 9, 29, 30, 40, 43, 55, 56, 67-69). Reduced levels of SMN due to a genetic defect cause spinal muscular atrophy, a severe neuromuscular disease that is characterized by degeneration of motor neurons in the spinal cord (6, 7, 21). SMN, as an oligomeric protein, is part of a large multiprotein complex that contains Gemin2 (30), the DEAD box RNA helicase Gemin3 (4), Gemin4 (5), Gemin5 (19), Gemin6 (52), and Gemin7 (1). Although the function of the SMN complex in snRNP assembly is its best-characterized activity, it most likely functions in the assembly, metabolism, and transport of various other RNPs, including snoRNPs, miRNPs, and the machineries that carry out transcription and pre-mRNA splicing (3, 12, 18, 24, 39, 44, 45, 49, 51, 53-55).
Purified snRNP total proteins, a preparation referred to as TPs, readily assemble an Sm core on a minimal Sm sequence oligonucleotide in vitro without ATP hydrolysis or other non-snRNP factors (59, 60, 64). However, in cell extracts the biogenesis of U snRNPs requires ATP hydrolysis (26, 40, 56), suggesting that snRNP proteins are not free to randomly associate with any uridine-rich RNA sequences in cells. Rather, it is the SMN complex that actively brings Sm proteins to U snRNAs, acting as a crucial specificity factor to ensure that highly stable Sm cores are only assembled on the correct snRNAs (56, 67, 69). Several components of the SMN complex bind directly to the Sm proteins, including the binding of SMN to the RG-rich C-terminal domains of the Sm proteins B, D1, and D3 (1, 1a, 3-5, 12, 19, 30, 52, 53). This interaction is enhanced by the symmetric dimethylarginine modification of specific arginines by the 20S methylosome that contains an arginine methyltransferase (JBP1/PRMT5) (13-15, 41). The SMN complex also binds directly and with sequence specificity to the Sm site containing U snRNAs. For U1 snRNA, the SMN complex-binding domain is contained within stem-loop 1 (68). For the other major U snRNAs, U2, U4, and U5, the minimal SMN complex-binding domains are closer to their 3' ends and contain the Sm site and the 3' stem-loop. These SMN complex-binding domains are necessary and sufficient for SMN complex binding and SMN-dependent assembly of Sm cores (67, 69). Previous studies have suggested that the SMN complex contains at least two separate high-affinity RNA binding domainsone for U1 snRNA and the other for U2, U4, and U5 snRNAs (67, 69).
Recently, we have shown that the Herpesvirus saimiri (HVS)-encoded small nuclear RNAs (HSURs 1 to 7) (46) also use the SMN complex to assemble Sm cores (16). HVS strain 11, the prototype gamma 2 herpesvirus, causes acute leukemias and T-cell lymphomas in some New World primates (8). The HSURs bind the SMN complex with very high affinity to the U4 snRNA-type binding site and can effectively compete with host snRNAs for snRNP assembly (16). Because the Sm sites and predicted secondary structures of the HSURs are simple, conserved, and have apparently evolved to closely resemble those of U2, U4, and U5 snRNAs (27, 28), it seems likely that their RNA motifs required for SMN complex binding and Sm core assembly might also be conserved. Therefore, we used the HSURs as a tool to identify the minimal RNA elements required for SMN complex binding and Sm core assembly.
Here we describe the essential features in an RNA that distinguish it and define it as an snRNA on which an Sm core will assemble, and we demonstrate that the SMN complex decodes these specific sequence features of an snRNA to determine its fate as a snRNP.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Labeling of RNAs. In vitro transcription and [32P]UTP labeling of RNAs were carried out as described previously (68). [32P]UTP-labeled RNAs were purified by electrophoresis on 7 M urea-6% polyacrylamide gels and precipitated with ethanol. RNAs were resuspended in deionized distilled water. The 5' or 3' end labeling of HSURs was carried out as described elsewhere (70).
Limited alkaline hydrolysis and minimal binding analysis. Limited alkaline hydrolysis was carried out as described previously (70).
Purification of native SMN complex. The SMN complex was purified from flag-Gemin2 HeLa Tet-ON cells as described previously (67). The parental HeLa cell line served as a negative control. For purification of SMN complex under low-salt conditions, SMN complex or control bound to anti-flag beads (Sigma) was washed extensively with RSB-100 (10 mM Tris-HCl [pH 7.5], 100 mM NaCl, 2.5 mM MgCl2) containing 0.02% NP-40. For complex purification under more stringent conditions, three additional washes were performed for 15 min each at 4°C with 10 bead volumes of RSB-500 containing 0.02% NP-40. The bound proteins were either equilibrated with 10 bead volumes of RSB-100 containing 0.01% NP-40 for binding experiments or eluted for 1 h at 4°C with 3x Flag peptide (Sigma) at a final concentration of 0.5 mg/ml for analysis by silver staining or Western blotting. Proteins were resolved on sodium dodecyl sulfate-12.5% polyacrylamide gels or NuPAGE Novex Bis-Tris precast gradient 4 to 12% mini-gels (Invitrogen). The following mouse monoclonal antibodies were used for Western blotting: 2B1 (anti-SMN), 12H12 (anti-Gemin3), 17D10 (anti-Gemin4), 10G11 (anti-Gemin5), Y12 (anti-Sm), and 3C2 (hnRNP K). A rabbit polyclonal antibody was used to detect Gemin6.
In vitro binding of RNAs. In vitro binding experiments were performed as previously described (67). The bound RNAs were isolated and analyzed by electrophoresis on 7 M urea-8% polyacrylamide gels.
Preparation of HeLa cell cytoplasmic extracts. HeLa cell cytoplasmic extracts competent for snRNP assembly were prepared as described previously (67) and immunodepletion of SMN complex was performed as described by Golembe et al. using anti-SMN monoclonal antibody (2B1) (16).
Assay for assembly of snRNPs. In vitro Sm core assembly and electrophoretic mobility shift assays were carried out as described previously (56). To quantitate the Sm core assembly, assembly reaction products were incubated with 4 µg of anti-Sm (Y12) monoclonal antibody or control antibody (SP2/0) conjugated to protein A-Sepharose CL-4B (Amersham) in RSB-500 (10 mM Tris-HCl [pH 7.5], 500 mM NaCl, 2.5 mM MgCl2) containing 0.1% NP-40 and 2 mg/ml heparin for 1 h at 4°C. Subsequently, the beads were washed five times with binding buffer and treated with proteinase K, and the immunoprecipitated RNAs were purified by phenol-chloroform extraction and ethanol precipitation. RNAs were analyzed by electrophoresis on 7 M urea-8% polyacrylamide gels and autoradiography.
RNase T1 digestion.
HSUR5-60 RNAs were labeled at the 5' end with [
-32P]ATP as described previously (70), and 20,000 cpm of each RNA was then incubated with RNase T1 (Ambion) according to the manufacturer's protocol. Digested RNAs were treated with proteinase K, and the RNAs were purified by phenol-chloroform extraction and ethanol precipitation and analyzed by electrophoresis on 7 M urea-12% polyacrylamide gels and autoradiography.
Phosphorothioate interference mapping.
HSUR4-35 and HSUR5-60 RNAs were transcribed using T7 polymerase in the presence of adenosine, uridine, guanosine, or cytidine (A, U, G, or C)
-thiotriphosphates (Glen Research) as described by Ryder et al. (61). The RNAs were purified by electrophoresis on 7 M urea-6% polyacrylamide gels, precipitated with ethanol, and labeled at the 5' end with [
-32P]ATP as described previously (70). A total of 100,000 cpm of each RNA was incubated with high-salt-washed SMN complex or nonspecific purified HeLa cell proteins immobilized on anti-flag beads (Sigma) in RSB-100 containing 0.01% NP-40 for 1 h at 4°C in the presence of 1 µM tRNA. For the interference experiments using purified snRNP TPs, 500,000 cpm of HSUR5-60 was incubated with purified TPs for 1 h at 30°C in the same buffer. RNAs with assembled Sm cores were immunopurified using Y12 antibody as described for snRNP assembly. Subsequently, the beads were washed five times with binding buffer and treated with proteinase K, and the RNAs were purified by phenol-chloroform extraction and ethanol precipitation. Precipitated RNAs were resuspended in 10 ml of loading buffer and cleaved at sites of phosphorothioate incorporation by addition of 1/10 volume of 2 mM I2 in ethanol. Equivalent cpm counts of RNA not subjected to SMN complex binding (input) were cleaved with I2 and run in parallel to normalize for phosphorothioate incorporation. The RNA fragments were resolved on either 7 M urea-10% polyacrylamide or 7 M urea-12% polyacrylamide sequencing gels for HSUR4-35 and HSUR5-60, respectively, and band intensities were quantified by PhosphorImager analysis. The interference value, kappa (
), at each position was calculated as described by McConnell et al. (38) and is the ratio of phosphorothioate incorporated over the phosphorothioate bound in the particle. According to Ryder et al. (61),
values of >2 indicate interferences, and values of <0.5 indicate enhancements; however, because the experiments presented here utilize a novel experimental approach, these values are used only as a guide.
Purification of native snRNP TPs. Native snRNP TPs were prepared as described previously (64). HeLa U snRNPs were immunopurified using anti-2,2,7-trimethylguanosine (mouse) agarose conjugate (Calbiochem). Proteins were resolved on NuPAGE Novex Bis-Tris precast 4 to 12% mini-gels (Invitrogen) and analyzed by silver staining or Western blotting.
Xenopus oocyte microinjections.
Injections were carried out as described in Fischer et al. (9). Briefly, oocytes were harvested and incubated for 2 h in modified Barth's solution containing 0.2% collagenase type II (Sigma). Defolliculated stage V and VI oocytes were collected and used the next day for microinjection. In a typical injection experiment, 20 nl of 32P-labeled RNAs (usually
1 x 106 cpm/ml for each RNA) were injected into the cytoplasm of oocytes. After a 1.5-h incubation, total extract was made and subjected to immunoprecipitation as described for snRNP assembly.
| RESULTS |
|---|
|
|
|---|
|
|
To examine the role of the SMN complex in the assembly of Sm cores on the minimal HSURs, cytoplasmic extracts were immunodepleted of the SMN complex prior to the assembly reaction. As previously demonstrated for full-length RNAs, the removal of the SMN complex resulted in loss of Sm core assembly on minimal RNAs (lanes 3, 6, 9, 12, 15, and 18), even though immunodepletion of SMN did not significantly reduce the amount of Sm proteins in the extracts (16, 56). The minimal domains of HSUR4 (HSUR4-35) and HSUR5 (HSUR5-60) assembled Sm cores in an SMN-dependent manner, although they appear to have reduced efficiency compared to the corresponding full-length RNAs (Fig. 2B, compare lanes 8 and 11 and 14 and 17). Overall, these experiments indicate that the minimal SMN complex-binding domains are sufficient for Sm core assembly.
A terminal 3' stem-loop is required for SMN complex binding and Sm core assembly. Because the presence of a 3' stem-loop is a common feature of the minimal SMN complex-binding domains of both the HSURs (Fig. 2A) and most of the U snRNAs (67), we wished to assess the importance of this structural feature for SMN complex binding and Sm core assembly. Toward this end, we carried out site-directed mutagenesis to destabilize the terminal stem in HSUR5-60 (Fig. 3A, des-stem). Limited RNase T1 digestion, which cleaves 3' of guanosines in single-stranded RNAs, confirmed the linearization of the stem structure (Fig. 3B). In addition, to determine if the stem-loop must be at the 3' end of the RNA, constructs were made that included either 15 or 70 additional nucleotides at the 3' end of HSUR5-60 (Fig. 3A, +15 nt and +70 nt). The RNAs were then labeled with [32P]UTP, mixed with labeled U6 snRNA as a negative control, and tested for binding to purified SMN complex or nonspecific immunopurified HeLa cell proteins as a negative control. As Fig. 3C shows, disruption of the secondary structure of the stem-loop strongly reduced SMN complex binding. In addition, a construct that completely removed the 3' stem-loop (Fig. 3C, no-stem) also showed a reduction in SMN complex binding (Fig. 3C). However, the addition of nucleotides to the 3' end of HSUR5-60 did not impair SMN complex binding (Fig. 3C), presumably because the SMN binding site itself (Fig. 2A) has not been altered. None of the RNAs tested bound to the negative control (data not shown).
|
|
|
Specific nucleotides of the Sm site are essential for SMN complex binding and Sm core assembly. In addition to the 3' stem-loop, the Sm site is a conserved feature among the minimal SMN complex-binding domains (Fig. 2A) (67). To determine if the conserved sequence of the Sm site is important for SMN complex binding, we produced mutations in the Sm site of HSUR5-60 (AUUUUUG) that changed uridines 1 through 5 to a cytosine one at a time, in addition to the adenosine and guanosine, which were changed to a cytosine and adenosine, respectively. The HSUR5-60 mutants were then labeled with [32P]UTP, mixed with U6 as a negative control, and bound to purified SMN complexes or nonspecific control proteins. As seen in Fig. 6A, substitution of the first or third uridines of the Sm site significantly reduced SMN complex binding by 80% and 90%, respectively, and a change in the second, fourth, or fifth uridines decreased SMN complex binding by 38 to 55%. Substitution of the Sm site adenosine also drastically reduced SMN complex binding, whereas substitution of the guanosine had no detectable effect (Fig. 6A). None of the Sm site mutants bound to the negative control (Fig. 6A). To differentiate between Sm site mutations that interfere with Sm protein binding versus mutations that affect SMN-dependent Sm core assembly, the Sm site mutants were incubated with either TPs or low-salt-purified SMN complex (Fig. 6B and C). Interestingly, TPs readily assembled an Sm core when any one of the Sm site positions was changed but did not assemble on a mutant that contains a double substitution in both the first and third uridines of the Sm site (Fig. 6C and data not shown). In contrast, a change to the first and/or third uridines of the Sm site caused a dramatic reduction in SMN-mediated Sm core assembly (Fig. 6B). Interestingly, when the fourth uridine is changed to a cytosine, the Sm site becomes identical to that of a subset of U1 snRNAs. Similar to the reduction in SMN complex binding observed for this substitution (Fig. 6A), the SMN-mediated Sm core assembly on this RNA was also reduced by at least one-half (data not shown). While the overall sequence of the Sm site appears to be important, these data suggest that the adenosine and first and third uridines of the Sm site are critical for SMN complex binding and SMN-mediated Sm core assembly.
|
-phosphorothioate-tagged nucleotide analogs into the phosphate backbone of the RNA molecule. After exposure to a functional assay, the tagged RNAs are recovered, and the phosphorothioate linkages are cleaved upon addition of iodine, producing a ladder on a sequencing gel (61). At a position where the substitution interferes with protein binding, a band of lower intensity will be present on the gel that is quantitatively represented as an increased kappa (
, or interference) value. Likewise, a reduction in the
value indicates a position of enhancement (61). To identify positions in the HSURs where phosphorothioate substitution affects SMN complex binding, HSUR5-60 and HSUR4-35 were transcribed in the presence of the adenosine (A), uridine (U), guanosine (G), or cytidine (C)
-thiotriphosphates, labeled at the 5' end with [
-32P]ATP and incubated with high-salt-washed immunopurified SMN complexes or nonspecifically immunopurified proteins as a control. The purified SMN complex appears to be free of Sm proteins, as their association is undetectable by both silver stain and Western blotting (Fig. 1A; see also Fig. 8D) (52, 56, 67, 68). Bound RNAs were then purified, cleaved with iodine, and analyzed by denaturing polyacrylamide gel electrophoresis.
|
values for the uridine positions of the two RNAs, which are increased for the first and third Sm site uridines. The kappa values that we consider significant range from 1.4 to 2.2; rather than the absolute values of the interferences, it is the relative differences in the values among the nucleotide positions that suggest an interaction with the SMN complex. Even though the Sm site adenosine also appears to be important for SMN complex binding (Fig. 6C), no specific interference was observed at this position or at any other A, C, or G position within the regions analyzed that has not been specifically mentioned (Fig. 7A and B and data not shown). Contacts with nucleotides in the 5' stem (C65) and the 3' loop (U89) of HSUR4-35 are also seen, but these contacts are not conserved in HSUR5-60, suggesting that they are not likely to be critical, especially specific nucleotides within the 3' stem-loop (Fig. 5). Because the HSURs share a common binding site on the SMN complex with U4 snRNA (16), a similar analysis of the minimal SMN complex-binding domain of U4 snRNA (67) was performed and also revealed an increase in the
values for the first and third Sm site uridines (data not shown). It is possible that the SMN complex also makes contacts at positions outside of the analyzed region or in a different manner that does not result in interference with phosphate backbone interactions. However, these results clearly indicate that SMN complex recognition of snRNAs does involve direct contact of the phosphate backbone of specific Sm site uridines.
|
) values revealed that the TPs do not contact the phosphate backbone at any position within the Sm site (Fig. 8B). Rather, interferences were numerically determined to occur only at positions outside of the Sm site, including U92, C86, and G109 within the region analyzed (Fig. 8C and data not shown). Importantly, the pattern of interference revealed by TPs is completely different from that of the SMN complex (compare Fig. 7 and 8), and the TPs used in this experiment do not contain any obvious traces of SMN complex components (Fig. 8D). This experiment demonstrates that direct contact of the Sm site is due to SMN complex, rather than Sm protein, interactions with the snRNA. | DISCUSSION |
|---|
|
|
|---|
|
The strong resemblance of the minimal SMN complex-binding domains of the HSURs to the domains in the major Sm site-containing U snRNAs, U2, U4, and U5 (previously shown to contain the SMN-binding sites [67]), argues that the features we define here are of general significance for snRNAs. The clear exception is U1 snRNA, which contains a distinctly different motif for binding to the SMN complex. In U1, the high-affinity binding site for the SMN complex is in stem-loop 1 and does not require the Sm site (67-69). Furthermore, the Sm site sequence of U1, AAUUU(C/G)UGG, is different from and not interchangeable with that of U5 snRNA (23). Consequently, U1 snRNA binds to the SMN complex through a sequence at its 5', rather than 3', end and at an independent binding site on the SMN complex, while the other U snRNAs and the HSURs share a second binding site (16, 67). Indeed, competition experiments suggest that there are at least two snRNA binding sites on the SMN complex, one for U1 snRNA and another for all the other snRNAs and the HSURs. Unlike Sm proteins, which promiscuously assemble an Sm core on single-stranded uridine-rich sequences in vitro (59), SMN complex recognition of an snRNA requires more. Consistent with previous assembly experiments that suggested that the Sm site might cooperate specifically with other elements of snRNAs for snRNP assembly (23), the data presented here suggest that the SMN complex recognizes the Sm site of an snRNA when it is presented within the context of a 3' stem-loop. Upon destabilization or removal of the stem-loop, SMN complex binding and SMN-mediated Sm core assembly are dramatically reduced (Fig. 3 and 4). However, in contrast to the critical uridines of the Sm site, the sequence of the stem-loop seems to be relatively unimportant (Fig. 5). This makes sense considering that the stem-loop sequences of the U snRNAs and HSURs do not appear to have extensive sequence conservation both within and between the two groups. Furthermore, five variants of U5 snRNA exist within cells that have various changes throughout their stem-loop sequences that do not affect their assembly into snRNPs (62). Via the assembly and selection of Sm cores on randomized RNAs in Xenopus oocytes, Grimm et al. (17) identified the motif AAUUUUUGG, located near the 3' stem of the carrier RNA, as the predominant sequence that confers Sm core assembly. As we now know that it is the SMN complex that both selects RNAs and mediates the assembly of Sm cores on them, these findings support the conclusion that sequences and structures unrelated to those defined here can function efficiently in SMN binding. Figure 9 summarizes the ranges of lengths of the 3' end stem and loop that exist among all U snRNAs and HSURs. Less is known about the requirement for sequences located 5' of the Sm site. Mapping data from both U snRNAs (67) and HSURs (this study) suggest that at least
15 nt are required 5' of the Sm site. Although there is no sequence or length conservation among the minimal 5' end regions, we cannot rule out that a specific sequence or that individual nucleotides specific to each RNA may be important for SMN complex binding. Although the SMN complex appears to contact the phosphate backbone of a cytosine in the stem 5' of the Sm site and a uridine in the 3' loop of HSUR4-35 (Fig. 7), these nucleotides are not conserved in HSUR5-60 and likely do not play the same role in the recognition by the SMN complex as do Sm site uridines. It is also possible that the 5' end may be required to maintain the overall secondary structure of the snRNA, to present a single-stranded Sm site, or to stabilize the Sm protein ring. In addition, there appears to be an upper limit on the length of the sequence just 3' of the SMN complex-binding element. Masuyama et al. (34) have recently shown that the length of the RNA determines the export pathway it utilizes. The addition of
300 nt to U1 snRNA shunted it to the mRNA export pathway, possibly influencing its activity and fate in the cytoplasm.
Binding to the SMN complex, while necessary, is not sufficient for Sm core assembly. The SMN complex binds to an RNA that has the right configuration of an Sm site sequence and an adjacent 3' stem-loop. This conclusion is further supported by experiments with a U1 snRNA construct (U1 Swap) that is identical to wild-type U1, except that the positions of stem-loops 1 and 4 were swapped, so that stem-loop 1 is placed 3' to the Sm site (U1 Swap) (67). While U1 Swap contains all the sequence elements required for SMN complex binding and Sm core assembly, including a high-affinity SMN complex binding site and an Sm site, the SMN complex discerns that the position of the Sm site relative to the 3' end of the RNA has been altered and, subsequently, will bind to but not assemble an Sm core on the RNA (67). It is currently not known if the distance between the Sm site and the 3' stem-loop is an important prerequisite in the assembly of an Sm core. Among all of the U snRNAs and HSURs, however, this length is maintained somewhere between 1 and 5 nt. In addition, if the RNA contains more than about 15 single-stranded nucleotides at the 3' end, the SMN complex will not assemble an Sm core on it, in marked contrast to the behavior of TPs (Fig. 3 and 4). Thus, binding and assembly are two distinct steps within the snRNP biogenesis pathway, and the SMN complex has a built-in surveillance capacity that aborts the assembly reaction if the RNA does not have all the correct features. It is not clear whether the aborted RNAs accumulate in the cytoplasm, are degraded, or are shortened via an exonucleolytic mechanism to become substrates for Sm core assembly. At least after a 1-h incubation, the elongated RNAs appear to remain full-length (Fig. 3). Other studies have reported that U1 snRNA molecules with heterogenous 3' ends do not efficiently assemble Sm cores and become poor substrates for normal 3'-end processing in Xenopus oocytes (50). In vivo, U snRNAs are transcribed as precursors that have been reported to contain as many as 6 to 8 nt more than the mature molecule (33), and Sm core assembly seems to be required for the 3' end processing (71).
The discovery that the SMN complex decodes the critical sequence features of snRNAs through direct binding offers a mechanism to explain how Sm cores are only assembled on the correct RNAs. These findings suggest a structural algorithm that can be used to predict additional snRNAs, if such exist, and possibly motor neuron-specific RNA substrates for the SMN complex. Viewed in the more general context of how cells distinguish among the different classes of RNAs, our studies reveal a clear signature in the major snRNAs and demonstrate that the SMN complex performs the task of identifying that signature as well as carrying out the assembly of these RNAs into the corresponding RNPs.
| ACKNOWLEDGMENTS |
|---|
This work was supported by the Association Française Contre les Myopathies (AFM) and by a grant from the National Institutes of Health. T.J.G. is a Predoctoral Fellow of the Howard Hughes Medical Institute. G.D. is an Investigator of the Howard Hughes Medical Institute.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
1. Brahms, H., Lo. Meheus, V. de Brabandere, U. Fischer, and R. Luhrmann. 2001. Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B' and the Sm-like protein LSm4, and their interaction with the SMN protein. RNA 7:1531-1542.[Abstract]
2. Branlant, C., A. Krol, J. P. Ebel, E. Lazar, B. Haendler, and M. Jacob. 1982. U2 RNA shares a structural domain with U1, U4, and U5 RNAs. EMBO J. 1:1259-1265.[Medline]
3. Buhler, D., V. Raker, R. Luhrmann, and U. Fischer. 1999. Essential role for the tudor domain of SMN in spliceosomal U snRNP assembly: implications for spinal muscular atrophy. Hum. Mol. Genet. 8:2351-2357.
4. Charroux, B., L. Pellizzoni, R. A. Perkinson, A. Shevchenko, M. Mann, and G. Dreyfuss. 1999. Gemin3: A novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems. J. Cell Biol. 147:1181-1194.
5. Charroux, B., L. Pellizzoni, R. A. Perkinson, J. Yong, A. Shevchenko, M. Mann, and G. Dreyfuss. 2000. Gemin4. A novel component of the SMN complex that is found in both gems and nucleoli. J. Cell Biol. 148:1177-1186.
6. Cifuentes-Diaz, C., T. Frugier, and J. Melki. 2002. Spinal muscular atrophy. Semin. Pediatr. Neurol. 9:145-150.[CrossRef][Medline]
7. Crawford, T. O., and C. A. Pardo. 1996. The neurobiology of childhood spinal muscular atrophy. Neurobiol. Dis. 3:97-110.[CrossRef][Medline]
8. Fickenscher, H., and B. Fleckenstein. 2001. Herpesvirus saimiri. Philos. Trans. R Soc. Lond. B 356:545-567.[CrossRef][Medline]
9. Fischer, U., Q. Liu, and G. Dreyfuss. 1997. The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 90:1023-1029.[CrossRef][Medline]
10. Fischer, U., and R. Luhrmann. 1990. An essential signaling role for the m3G cap in the transport of U1 snRNP to the nucleus. Science 249:786-790.
11. Fischer, U., V. Sumpter, M. Sekine, T. Satoh, and R. Luhrmann. 1993. Nucleo-cytoplasmic transport of U snRNPs: definition of a nuclear location signal in the Sm core domain that binds a transport receptor independently of the m3G cap. EMBO J. 12:573-583.[Medline]
12. Friesen, W. J., and G. Dreyfuss. 2000. Specific sequences of the Sm and Sm-like (Lsm) proteins mediate their interaction with the spinal muscular atrophy disease gene product (SMN). J. Biol. Chem. 275:26370-26375.
13. Friesen, W. J., S. Massenet, S. Paushkin, A. Wyce, and G. Dreyfuss. 2001. SMN, the product of the spinal muscular atrophy gene, binds preferentially to dimethylarginine-containing protein targets. Mol. Cell 7:1111-1117.[CrossRef][Medline]
14. Friesen, W. J., S. Paushkin, A. Wyce, S. Massenet, G. S. Pesiridis, G. Van Duyne, J. Rappsilber, M. Mann, and G. Dreyfuss. 2001. The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins. Mol. Cell. Biol. 21:8289-8300.
15. Friesen, W. J., A. Wyce, S. Paushkin, L. Abel, J. Rappsilber, M. Mann, and G. Dreyfuss. 2002. A novel WD repeat protein component of the methylosome binds Sm proteins. J. Biol. Chem. 277:8243-8247.
16. Golembe, T. J., J. Yong, D. J. Battle, W. Feng, L. Wan, and G. Dreyfuss. 2005. Lymphotropic Herpesvirus saimiri uses the SMN complex to assemble Sm cores on its small RNAs. Mol. Cell. Biol. 25:602-611.
17. Grimm, C., E. Lund, and J. E. Dahlberg. 1997. In vivo selection of RNAs that localize in the nucleus. EMBO J. 16:793-806.[CrossRef][Medline]
18. Gubitz, A. K., W. Feng, and G. Dreyfuss. 2004. The SMN complex. Exp. Cell Res. 296:51-56.[CrossRef][Medline]
19. Gubitz, A. K., Z. Mourelatos, L. Abel, J. Rappsilber, M. Mann, and G. Dreyfuss. 2002. Gemin5, a novel WD repeat protein component of the SMN complex that binds Sm proteins. J. Biol. Chem. 277:5631-5636.
20. Hamm, J., N. A. Dathan, D. Scherly, and I. W. Mattaj. 1990. Multiple domains of U1 snRNA, including U1 specific protein binding sites, are required for splicing. EMBO J. 9:1237-1244.[Medline]
21. Iannaccone, S. T., S. A. Smith, and L. R. Simard. 2004. Spinal muscular atrophy. Curr. Neurol. Neurosci. Rep. 4:74-80.[Medline]
22. Imai, Y., Y. Matsushima, T. Sugimura, and M. Terada. 1991. A simple and rapid method for generating a deletion by PCR. Nucleic Acids Res. 19:2785.
23. Jarmolowski, A., and I. W. Mattaj. 1993. The determinants for Sm protein binding to Xenopus U1 and U5 snRNAs are complex and non-identical. EMBO J. 12:223-232.[Medline]
24. Jones, K. W., K. Gorzynski, C. M. Hales, U. Fischer, F. Badbanchi, R. M. Terns, and M. P. Terns. 2001. Direct interaction of the spinal muscular atrophy disease protein SMN with the small nucleolar RNA-associated protein fibrillarin. J. Biol. Chem. 276:38645-38651.
25. Kambach, C., S. Walke, R. Young, J. M. Avis, E. de la Fortelle, V. A. Raker, R. Luhrmann, J. Li, and K. Nagai. 1999. Crystal structures of two Sm protein complexes and their implications for the assembly of the spliceosomal snRNPs. Cell 96:375-387.[CrossRef][Medline]
26. Kleinschmidt, A. M., J. R. Patton, and T. Pederson. 1989. U2 small nuclear RNP assembly in vitro. Nucleic Acids Res. 17:4817-4828.
27. Lee, S. I., S. C. Murthy, J. J. Trimble, R. C. Desrosiers, and J. A. Steitz. 1988. Four novel U RNAs are encoded by a herpesvirus. Cell 54:599-607.[CrossRef][Medline]
28. Lee, S. I., and J. A. Steitz. 1990. Herpesvirus saimiri U RNAs are expressed and assembled into ribonucleoprotein particles in the absence of other viral genes. J. Virol. 64:3905-3915.
29. Liu, Q., and G. Dreyfuss. 1996. A novel nuclear structure containing the survival of motor neurons protein. EMBO J. 15:3555-3565.[Medline]
30. Liu, Q., U. Fischer, F. Wang, and G. Dreyfuss. 1997. The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 90:1013-1021.[CrossRef][Medline]
31. Luhrmann, R. 1990. Functions of U-snRNPs. Mol. Biol. Rep. 14:183-192.[CrossRef][Medline]
32. Luhrmann, R., B. Kastner, and M. Bach. 1990. Structure of spliceosomal snRNPs and their role in pre-mRNA splicing. Biochim. Biophys. Acta 1087:265-292.[Medline]
33. Madore, S. J., E. D. Wieben, and T. Pederson. 1984. Intracellular site of U1 small nuclear RNA processing and ribonucleoprotein assembly. J. Cell Biol. 98:188-192.
34. Masuyama, K., I. Taniguchi, N. Kataoka, and M. Ohno. 2004. RNA length defines RNA export pathway. Genes Dev. 18:2074-2085.
35. Mattaj, I. W. 1986. Cap trimethylation of U snRNA is cytoplasmic and dependent on U snRNP protein binding. Cell 46:905-911.[CrossRef][Medline]
36. Mattaj, I. W., W. Boelens, E. Izaurralde, A. Jarmolowski, and C. Kambach. 1993. Nucleocytoplasmic transport and snRNP assembly. Mol. Biol. Rep. 18:79-83.[CrossRef][Medline]
37. Mattaj, I. W., and E. M. De Robertis. 1985. Nuclear segregation of U2 snRNA requires binding of specific snRNP proteins. Cell 40:111-118.[CrossRef][Medline]
38. McConnell, T. S., R. P. Lokken, and J. A. Steitz. 2003. Assembly of the U1 snRNP involves interactions with the backbone of the terminal stem of U1 snRNA. RNA 9:193-201.
39. Meister, G., D. Buhler, B. Laggerbauer, M. Zobawa, F. Lottspeich, and U. Fischer. 2000. Characterization of a nuclear 20S complex containing the survival of motor neurons (SMN) protein and a specific subset of spliceosomal Sm proteins. Hum. Mol. Genet. 9:1977-1986.
40. Meister, G., D. Buhler, R. Pillai, F. Lottspeich, and U. Fischer. 2001. A multiprotein complex mediates the ATP-dependent assembly of spliceosomal U snRNPs. Nat. Cell. Biol. 3:945-949.[CrossRef][Medline]
41. Meister, G., C. Eggert, D. Buhler, H. Brahms, C. Kambach, and U. Fischer. 2001. Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln. Curr. Biol. 11:1990-1994.[CrossRef][Medline]
42. Meister, G., C. Eggert, and U. Fischer. 2002. SMN-mediated assembly of RNPs: a complex story. Trends Cell Biol. 12:472-478.[CrossRef][Medline]
43. Meister, G., and U. Fischer. 2002. Assisted RNP assembly: SMN and PRMT5 complexes cooperate in the formation of spliceosomal UsnRNPs. EMBO J. 21:5853-5863.[CrossRef][Medline]
44. Mourelatos, Z., L. Abel, J. Yong, N. Kataoka, and G. Dreyfuss. 2001. SMN interacts with a novel family of hnRNP and spliceosomal proteins. EMBO J. 20:5443-5452.[CrossRef][Medline]
45. Mourelatos, Z., J. Dostie, S. Paushkin, A. Sharma, B. Charroux, L. Abel, J. Rappsilber, M. Mann, and G. Dreyfuss. 2002. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 16:720-728.
46. Murthy, S., J. Kamine, and R. C. Desrosiers. 1986. Viral-encoded small RNAs in herpes virus saimiri induced tumors. EMBO J. 5:1625-1632.[Medline]
47. Myer, V. E., S. I. Lee, and J. A. Steitz. 1992. Viral small nuclear ribonucleoproteins bind a protein implicated in messenger RNA destabilization. Proc. Natl. Acad. Sci. USA 89:1296-1300.
48. Nagai, K., Y. Muto, D. A. Pomeranz Krummel, C. Kambach, T. Ignjatovic, S. Walke, and A. Kuglstatter. 2001. Structure and assembly of the spliceosomal snRNPs. Novartis Medal Lecture. Biochem. Soc. Trans. 29:15-26.
49. Narayanan, U., T. Achsel, R. Luhrmann, and A. G. Matera. 2004. Coupled in vitro import of U snRNPs and SMN, the spinal muscular atrophy protein. Mol. Cell 16:223-234.[CrossRef][Medline]
50. Neuman de Vegvar, H. E., and J. E. Dahlberg. 1990. Nucleocytoplasmic transport and processing of small nuclear RNA precursors. Mol. Cell. Biol. 10:3365-3375.